中国临床医学2025，Vol.32Issue(3)：321-326,6.DOI:10.12025/j.issn.1008-6358.2025.20250107
从国际脂肪性肝病定义的变迁看2024版中国指南的工作定义与特色
The evolution of international definitions of fatty liver disease and insights into the working definition and features of the 2024 Chinese guideline
摘要
Abstract
Since 2020,the international community has successively proposed new nomenclatures for metabolic dysfunction-associated fatty liver disease(MAFLD)and metabolic dysfunction-associated steatotic liver disease(MASLD).In 2024,the Chinese Society of Hepatology updated and published the Guideline for the prevention and treatment of metabolic dysfunction-associated(non-alcoholic)fatty liver disease(version 2024).This review deeply analyzes the differences between MASLD and MAFLD in terms of concept,definition framework,and clinical management.On this basis,it provides an in-depth interpretation of the updated highlights and features of the working definition in the 2024 updated Chinese guideline.关键词
代谢功能障碍相关脂肪性肝病/代谢功能障碍相关脂肪变性肝病/临床实践指南Key words
metabolic dysfunction-associated fatty liver disease/metabolic dysfunction-associated steatotic liver disease/clinical practice guideline分类
医药卫生引用本文复制引用
陈立,范建高..从国际脂肪性肝病定义的变迁看2024版中国指南的工作定义与特色[J].中国临床医学,2025,32(3):321-326,6.基金项目
国家自然科学基金(82472258),国家科技重大专项(2023ZD0508700).Supported by National Natural Science Foundation of China(82472258)and National Science and Technology Major Project(2023ZD0508700). （82472258）
